APO-SORAFENIB DIN 02490641
Status: Approved
Holder: APOTEX INC
Health Canada record
| Active ingredient(s) | SORAFENIB (SORAFENIB TOSYLATE) 200 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | L01EX02 SORAFENIB |
|---|
| Original market date | |
|---|
| Current status date | 28-Nov-2022 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SORAFENIB (SORAFENIB TOSYLATE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02284227 | NEXAVAR | BAYER INC | Tablet | SORAFENIB (SORAFENIB TOSYLATE) 200 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 29577 | 2022-11-28 | Abbreviated New Drug Submission (ANDS) | |
Request a quote for APO-SORAFENIB
How to read a Canadian DIN record